Metallothionein isoform 3 expression inhibits cell growth and increases drug resistance of PC-3 prostate cancer cells

Prostate. 2002 Jul 1;52(2):89-97. doi: 10.1002/pros.10097.

Abstract

Background: The third isoform of metallothionein (MT-3) is overexpressed in prostate cancers and PIN lesions. The expression of MT-3 is highly variable but appears to correlate to Gleason score. The goal of the present study was to determine the effect of MT-3 overexpression on the growth of the PC-3 prostate cancer cell line.

Methods: PC-3 cells were stably transfected with either the MT-3 or MT-1E gene. Cell growth was determined by counting DAPI-stained nuclei, drug resistance by the colony formation assay, MT mRNA expression by reverse transcriptase-polymerase chain reaction, and MT protein by immunoblot.

Results: PC-3 cells that overexpress the MT-3 gene are growth inhibited compared with either untransfected cells, cells with blank vector, or cells with similar overexpression of the MT-1E gene. Furthermore, increased chemotherapeutic drug resistance occurred in PC-3 clones derived from MT-3- and MT-1E-transfected cells.

Conclusion: The overexpression of MT-3 can influence the growth and chemotherapeutic drug resistance of the PC-3 prostate cancer cell line.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Division
  • Drug Resistance, Neoplasm*
  • Gene Expression*
  • Growth Inhibitors / genetics*
  • Humans
  • Male
  • Metallothionein 3
  • Nerve Tissue Proteins / genetics*
  • Prostatic Neoplasms / genetics
  • Prostatic Neoplasms / pathology*
  • Prostatic Neoplasms / physiopathology
  • Tumor Cells, Cultured

Substances

  • Growth Inhibitors
  • Metallothionein 3
  • Nerve Tissue Proteins